A nanoparticle vaccine designed to fight cancers induced by human papillomavirus (HPV) eradicated tumors in an animal model of late-stage metastatic disease, UT Southwestern Medical Center scientists report in a new study published in the […]
Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) report encouraging results from an early phase clinical trial that found an experimental intranasal vaccine triggered a broad […]
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.This post was originally published on this site
A new study shows children and young people face long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or without an infection. Meanwhile, the COVID-19 vaccination was only […]
Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial pathogens. This starts them on a burdensome path […]
When four states between 2015 and 2021 stopped allowing parents to opt their children out of receiving routine vaccines without a medical reason, vaccination rates among kindergartners increased substantially. That’s the key finding from our […]
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost […]
An Oxford-led study has demonstrated that an oral live-attenuated vaccine, CVD 1902, provided significant protection against S. Paratyphi A infection in healthy adults using a controlled human infection model, without any safety concerns. The research […]
As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists are learning why vaccines can trigger a weaker response in older adults, around age 65, and what […]
The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of new vaccines. A team of researchers at Purdue University and Merck & Co. Inc., known as Merck […]
© 2024 EarnWithSocial.ca - Canada's Technology News and Highlights | Read. Learn. Share.